Research Strategy

Eyes on the Future is committed to advance research on RDH12 Inherited Retinal Dystrophies against 4 key priorities:

Gene Therapy

Pre-clinical and clinical development of a gene replacement therapy for RDH12

Small Molecules

Pre-clinical and clinical development of potential small molecules therapies to slow down the sight loss

FOUNDATIONAL DISEASE UNDERSTANDING

Expand the basic understanding of RDH12 Retinal Dystrophy disease mechanism and pathways

NATURAL HISTORY & DISEASE PROGRESSION

Study RDH12 disease progression through patient data and retina imaging to drive trial endpoints definition

If you are a researcher interested in doing work on RDH12 please contact us.

Further information can be found in the Research Strategy and Grant Terms & Conditions.